Evidence map›Paper›PMID 39401901›Full record

ReviewProceedings of the Japan Academy. Series B, Physical and biological sciences2024

Imaging-based chemogenetics for dissecting neural circuits in nonhuman primates.

Takafumi Minamimoto, Yuji Nagai, Kei Oyama

Abstract readReview
In one paragraph

Review in Proceedings of the Japan Academy. Series B, Physical and biological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Takafumi MinamimotoAdvanced Neuroimaging Center, National Institutes for Quantum Science and Technology, Chiba, Japan.ORCID http://orcid.org/0000-0003-4305-0174
Yuji NagaiAdvanced Neuroimaging Center, National Institutes for Quantum Science and Technology, Chiba, Japan.ORCID http://orcid.org/0000-0001-7005-0749
Kei OyamaAdvanced Neuroimaging Center, National Institutes for Quantum Science and Technology, Chiba, Japan.ORCID http://orcid.org/0000-0002-3375-7099

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonhuman primates, particularly macaque and marmoset monkeys, serve as invaluable models for studying complex brain functions and behavior. However, the lack of suitable genetic neuromodulation tools has constrained research at the network level. This review examines the application of a chemogenetic technology, specifically, designer receptors exclusively activated by designer drugs (DREADDs), to nonhuman primates. DREADDs offer a means of reversibly controlling neuronal activity within a specific cell type or neural pathway, effectively targeting multiple brain regions simultaneously. The combination of DREADDs with imaging techniques, such as positron emission tomography and magnetic resonance imaging, has significantly enhanced nonhuman primate research, facilitating the precise visualization and manipulation of specific brain circuits and enabling the detailed monitoring of changes in network activity, which can then be correlated with altered behavior. This review outlines these technological advances and considers their potential for enhancing our understanding of primate brain circuit function and developing novel therapeutic approaches for treating brain diseases.

Indexed as

BrainPrimatesAnimalsHumansMagnetic Resonance ImagingNerve NetPositron-Emission TomographyDREADDmonkeyneuroimagingneuromodulationpositron emission tomography

Identifiers

PMID39401901
PMCPMC11535006

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.